Evidence map›Paper›PMID 32264846›Full record

ArticleBMC infectious diseases2020

Epidemiological characteristics and transmissibility of shigellosis in Hubei Province, China, 2005 - 2017.

Qi Chen, Jia Rui, Qingqing Hu, Ying Peng, Hao Zhang, Zeyu Zhao, Yeqing Tong, Yang Wu, Yanhua Su, Benhua Zhao and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Capsaicin InhibitsFrontiers in pharmacology · 2022
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Qi ChenHubei Provincial Center for Disease Control and Prevention, NO.6 Zhuodaoquan North Road, Hongshan District, Wuhan City, Hubei Province, People's Republic of China.
Jia RuiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, 4221-117 South Xiang'an Road, Xiang'an District, Xiamen City, Fujian Province, People's Republic of China.
Qingqing HuDivision of Public Health, School of Medicine, University of Utah, 201 Presidents Circle, Salt Lake City, UT, 84112, USA.
Ying PengWuhan Center for Disease Control and Prevention, Wuhan City, Hubei Province, People's Republic of China.
Hao ZhangYichang Center for Disease Control and Prevention, Yichang City, Hubei Province, People's Republic of China.
Zeyu ZhaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, 4221-117 South Xiang'an Road, Xiang'an District, Xiamen City, Fujian Province, People's Republic of China.
Yeqing TongHubei Provincial Center for Disease Control and Prevention, NO.6 Zhuodaoquan North Road, Hongshan District, Wuhan City, Hubei Province, People's Republic of China.
Yang WuHubei Provincial Center for Disease Control and Prevention, NO.6 Zhuodaoquan North Road, Hongshan District, Wuhan City, Hubei Province, People's Republic of China.
Yanhua SuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, 4221-117 South Xiang'an Road, Xiang'an District, Xiamen City, Fujian Province, People's Republic of China.
Benhua ZhaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, 4221-117 South Xiang'an Road, Xiang'an District, Xiamen City, Fujian Province, People's Republic of China.
Xuhua GuanHubei Provincial Center for Disease Control and Prevention, NO.6 Zhuodaoquan North Road, Hongshan District, Wuhan City, Hubei Province, People's Republic of China. guanxh9999@163.com.
Tianmu ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, 4221-117 South Xiang'an Road, Xiang'an District, Xiamen City, Fujian Province, People's Republic of China. 13698665@qq.com.
Xiamen University · CNHubei Provincial Center for Disease Control and Prevention · CNSecond Hospital of Yichang · CNUniversity of Utah · USWuhan Center for Disease Control and Prevention · CN

Funding

The Key Support Project of Hubei Health and Family Planning Commission of China WJ2017Z018The Open Research Fund of State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics SKLVD2018KF001, SKLVD2018KF002The Special innovative team project of Hubei Health and Family Planning Commission of China WJ2016JT-007
6 · The paper itself

Abstract

backgroundShigellosis is one of the main diarrhea diseases in developing countries. However, the transmissibility of shigellosis remains unclear.

methodsWe used the dataset of shigellosis cases reported between January 2005 and December 2017, from Hubei Province, China. A mathematical model was developed based on the natural history and the transmission mechanism of the disease. By fitting the data using the model, transmission relative rate from person to person (b) and from reservoir to person (b

resultsA total of 130,770 shigellosis cases were reported in Hubei province, among which 13 cases were dead. The median annual incidence was 19.96 per 100,000 persons (range: 5.99 per 100,000 persons - 29.47 per 100,000 persons) with a decreased trend (trend χ

conclusionsThe incidence of shigellosis is still in high level. The transmissibility of the disease is low in Hubei Province. The transmission would be interrupted in the year of 2029.

Indexed as

EpidemicsAdolescentAdultAgedAge FactorsChildChild, PreschoolChinaDeveloping CountriesDysentery, BacillaryFecesFemaleHumansIncidenceInfantInfant, NewbornEffective reproduction numberMathematical modelShigellosisTransmissibility

Identifiers

PMID32264846
PMCPMC7136996
OpenAlexW3014766772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.